Liver stiffness test for liver failure patients
Part of Digestive system clinical trials.
This trial tests if a special ultrasound (elastography) can help measure liver damage in people with liver failure. It may find problems like confusion, bleeding, fluid buildup, or liver cancer earlier.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have liver failure, which may cause problems like confusion, vomiting blood, belly swelling, or liver cancer.
- You are not pregnant or breastfeeding.
- You are willing to take part in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special ultrasound technique called elastography to measure how stiff the liver is in children with cholestatic liver disease. The goal is to see how well this test can detect liver scarring (fibrosis) compared to a liver biopsy.
This study uses an ultrasound probe during a routine endoscopy to measure liver stiffness, which can help detect liver scarring (fibrosis) in people with fatty liver disease (MASLD). If you are already scheduled for an endoscopy and have no signs of advanced liver scarring, you may be able to join.
This trial tests a special ultrasound technique during an endoscopy to see how well it can detect changes in the liver from non-alcoholic fatty liver disease. It may help improve non-invasive assessment before or alongside a follow-up liver biopsy.
This trial uses a special ultrasound during endoscopy to measure liver and spleen stiffness. It may replace liver biopsy for some patients with cirrhosis or unexplained high liver enzymes.
This trial tests a new wearable patch that uses ultrasound to measure liver stiffness, which can help diagnose scarring. It may be an option if you already need or recently had a FibroScan for chronic liver disease.
This trial uses MR elastography (a special MRI) to measure liver stiffness and check for fibrosis (scarring) without a needle biopsy. It may help guide treatment for chronic hepatitis B.
Hear when a new Liver Cell Damage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.